Meta-analysis of 3 placebo-controlled trials (9013 patients with HFmrEF or HFrEF): digitalis glycosides were associated with less CV death or first worsening HF (41% vs 45%; HR 0.85), mainly fewer worsening HF events; all-cause death did not differ (HR 0.97).
Meta-analysisn = 9,013
Damman et al. Efficacy and Safety of Digitalis Glycosides in Heart Failure: A Meta-Analysis